OTCMKTS:BGMD - BG Medicine Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.0460 0.00 (0.00 %)
(As of 07/17/2018 04:00 PM ET)
Previous Close$0.0480
Today's Range$0.0275 - $0.0460
52-Week Range$0.02 - $0.09
Volume37,400 shs
Average Volume14,611 shs
Market Capitalization$340,000.00
P/E RatioN/A
Dividend YieldN/A
Beta3.27
BG Medicine logoBG Medicine, Inc. engages in development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.

Receive BGMD News and Ratings via Email

Sign-up to receive the latest news and ratings for BGMD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Diagnostic substances
Sub-IndustryLife Sciences Tools & Services
SectorMedical
SymbolOTCMKTS:BGMD
CUSIP08861T10
Phone781-890-1199

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.57 million
Price / Sales0.33
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares11,370,000
Market Cap$0.34

The Truth About Cryptocurrencies

BG Medicine (OTCMKTS:BGMD) Frequently Asked Questions

What is BG Medicine's stock symbol?

BG Medicine trades on the OTCMKTS under the ticker symbol "BGMD."

How were BG Medicine's earnings last quarter?

BG Medicine, Inc. (OTCMKTS:BGMD) issued its quarterly earnings data on Tuesday, November, 17th. The medical research company reported ($0.27) earnings per share for the quarter. The medical research company had revenue of $334 million for the quarter, compared to analyst estimates of $695 million. View BG Medicine's Earnings History.

What is the consensus analysts' recommendation for BG Medicine?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BG Medicine in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Who are some of BG Medicine's key competitors?

Who are BG Medicine's key executives?

BG Medicine's management team includes the folowing people:
  • Dr. Paul R. Sohmer, CEO, Pres & Director (Age 69)
  • Mr. Stephen P. Hall, CFO, Exec. VP & Treasurer (Age 67)
  • Dr. Aram Adourian, Chief Scientific Officer (Age 48)

Has BG Medicine been receiving favorable news coverage?

News stories about BGMD stock have been trending somewhat positive on Tuesday, Accern Sentiment reports. The research firm identifies negative and positive news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. BG Medicine earned a media sentiment score of 0.02 on Accern's scale. They also assigned media stories about the medical research company an impact score of 46.63 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of BG Medicine?

Shares of BGMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BG Medicine's stock price today?

One share of BGMD stock can currently be purchased for approximately $0.0460.

How big of a company is BG Medicine?

BG Medicine has a market capitalization of $340,000.00 and generates $1.57 million in revenue each year.

How can I contact BG Medicine?

BG Medicine's mailing address is 303 Wyman Street Suite 300, Waltham MA, 02451. The medical research company can be reached via phone at 781-890-1199 or via email at [email protected]


MarketBeat Community Rating for BG Medicine (OTCMKTS BGMD)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  67 (Vote Outperform)
Underperform Votes:  60 (Vote Underperform)
Total Votes:  127
MarketBeat's community ratings are surveys of what our community members think about BG Medicine and other stocks. Vote "Outperform" if you believe BGMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BGMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.